Desheng Xiao
Papers
1
Total Citations
24
H-Index
1
About
Dr. Desheng Xiao is a leading thoracic surgeon whose research focuses on the intersection of advanced surgical robotics and multimodal cancer therapy for non-small cell lung cancer (NSCLC). His major contributions center on evaluating the feasibility and safety of robotic-assisted thoracic surgery (RATS) following neoadjuvant chemoimmunotherapy, a critical area for improving outcomes in patients with stage III NSCLC—a notoriously heterogeneous and challenging disease with historically poor prognoses. In his landmark 2022 real-world prospective cohort study, Dr. Xiao demonstrated that combining cutting-edge robotic techniques with modern immunotherapy regimens is both safe and practical, offering new hope for this complex patient population. His work has garnered significant attention, with this pivotal paper accumulating 24 citations, underscoring its influence on clinical practice and surgical oncology. By systematically addressing the surgical management of stage III NSCLC, Dr. Xiao has helped bridge the gap between immunotherapy advancements and minimally invasive surgical approaches, establishing himself as a key figure in the evolution of precision thoracic surgery.
Research Focus
Key Achievements
Top Papers
- 1